Phase II study of lapatinib in combination with vinorelbine in patients with HER2 positive recurrent or metastatic breast cancer: A multicentric Turkish Oncology Group (TOG) trial

Date
2013
Author
ÖZKAN, METİN
Cetin, B.
Benekli, M.
Kucukoner, M.
Isikdogan, A.
Basaran, G.
Onur, H.
Eralp, Y.
Sen, F.
Un, O.
Saip, P.
Karaca, H.
Metadata
Show full item record
Abstract
Background: The aim of this explorative phase II study was to evaluate the activity and safety of lapatinib in combination with intravenous vinorelbine in women with HER2 positive metastatic or recurrent breast cancer.
URI
http://hdl.handle.net/20.500.12627/118452
https://doi.org/10.1016/j.breast.2013.07.048
Collections